©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
NURS 384 - Exam 2 Study Guide
Solutions
Cholesterol - Ans:✔✔-<200 mg/dL
HDL - Ans:✔✔->40 mg/dL
LDL - Ans:✔✔-<130 mg/dL
triglycerides - Ans:✔✔-<150 mg/dL
hematocrit - Ans:✔✔-36% - 50%
hemoglobin - Ans:✔✔-12 - 18
atorvastatin (Lipitor) - Ans:✔✔-- lowers cholesterol
- Do not give with grapefruit, check liver function prior to giving; these can cause toxicity.
- Observe for signs of toxicity; muscle pain, and rhabdomyolysis.
- Nausea, flatulence, and constipation are adverse effects. This is the most important class of lipid
lowering medications, and most frequently prescribed.
Page 1/61
, ©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
- Cholesterol is synthesized at night so instruct patient to take at night for best efficacy.
MAP - Ans:✔✔-(SBP + 2 DBP) / 3
Diagnosis of diabetes - Ans:✔✔-A1C >6.5%
Most common problem of CAD - Ans:✔✔-atherosclerosis
CAD non-modifiable risk factors - Ans:✔✔-age, gender, ethnicity, family history, genetics
CAD modifiable risk factors - Ans:✔✔-- cholesterol > 200
- HDL < 40 mg/dL
- LDL > 130 mg/dL
- Triglycerides > 150 mg/dL
- Tobacco use
- BP
MI locations of radiation - Ans:✔✔-back, neck, jaw, shoulder, arm
chronic stable angina - Ans:✔✔-only ischemia
unstable angina - Ans:✔✔-partial thrombus occlusion
Page 2/61
, ©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
non-STEMI - Ans:✔✔-occluding thrombus causes tissue necrosis, elevated cardiac enzymes - may see
ECG changes but not ST elevation
STEMI - Ans:✔✔-Complete thrombus occlusion causing infarction of the tissue, will see ST elevation or
LBBB
Treatment for stable angina - Ans:✔✔-A Antiplatelet, antianginal, anticoagulant, ace arb
B Beta blocker BP control
C Cigarette smoking, cholesterol mgmt., CCB, cardiac rehab
D diet, diabetes mgmt., depression screening, vaso dilator (nitroglycerin)
E education, exercise
F flu vaccination
MI s/s - Ans:✔✔-- pain: tightness, crushing, substernal, unrelieved by nitro
- dyspnea
- nausea
- vomiting
- diaphoresis
Page 3/61
, ©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
- denial
- increased HR
- decreased BP
ST elevation - Ans:✔✔->1mm in two contiguous limb leads or >2mm in two contiguous chest leads
MI lab test - Ans:✔✔-- Troponin I & T
- Creatine kinase -MB
- Myoglobin
- C-reactive protein
MI nursing intervention - Ans:✔✔-- ABCs
- Aspirin
- O2 if low
- monitor ECG
- repeat 12-lead ECG & blood work
- pain relief with nitrate first then opioid if needed
Page 4/61
FIRST PUBLISH OCTOBER 2024
NURS 384 - Exam 2 Study Guide
Solutions
Cholesterol - Ans:✔✔-<200 mg/dL
HDL - Ans:✔✔->40 mg/dL
LDL - Ans:✔✔-<130 mg/dL
triglycerides - Ans:✔✔-<150 mg/dL
hematocrit - Ans:✔✔-36% - 50%
hemoglobin - Ans:✔✔-12 - 18
atorvastatin (Lipitor) - Ans:✔✔-- lowers cholesterol
- Do not give with grapefruit, check liver function prior to giving; these can cause toxicity.
- Observe for signs of toxicity; muscle pain, and rhabdomyolysis.
- Nausea, flatulence, and constipation are adverse effects. This is the most important class of lipid
lowering medications, and most frequently prescribed.
Page 1/61
, ©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
- Cholesterol is synthesized at night so instruct patient to take at night for best efficacy.
MAP - Ans:✔✔-(SBP + 2 DBP) / 3
Diagnosis of diabetes - Ans:✔✔-A1C >6.5%
Most common problem of CAD - Ans:✔✔-atherosclerosis
CAD non-modifiable risk factors - Ans:✔✔-age, gender, ethnicity, family history, genetics
CAD modifiable risk factors - Ans:✔✔-- cholesterol > 200
- HDL < 40 mg/dL
- LDL > 130 mg/dL
- Triglycerides > 150 mg/dL
- Tobacco use
- BP
MI locations of radiation - Ans:✔✔-back, neck, jaw, shoulder, arm
chronic stable angina - Ans:✔✔-only ischemia
unstable angina - Ans:✔✔-partial thrombus occlusion
Page 2/61
, ©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
non-STEMI - Ans:✔✔-occluding thrombus causes tissue necrosis, elevated cardiac enzymes - may see
ECG changes but not ST elevation
STEMI - Ans:✔✔-Complete thrombus occlusion causing infarction of the tissue, will see ST elevation or
LBBB
Treatment for stable angina - Ans:✔✔-A Antiplatelet, antianginal, anticoagulant, ace arb
B Beta blocker BP control
C Cigarette smoking, cholesterol mgmt., CCB, cardiac rehab
D diet, diabetes mgmt., depression screening, vaso dilator (nitroglycerin)
E education, exercise
F flu vaccination
MI s/s - Ans:✔✔-- pain: tightness, crushing, substernal, unrelieved by nitro
- dyspnea
- nausea
- vomiting
- diaphoresis
Page 3/61
, ©GRACEAMELIA 2024/2025 ACADEMIC YEAR. ALL RIGHTS RESERVED
FIRST PUBLISH OCTOBER 2024
- denial
- increased HR
- decreased BP
ST elevation - Ans:✔✔->1mm in two contiguous limb leads or >2mm in two contiguous chest leads
MI lab test - Ans:✔✔-- Troponin I & T
- Creatine kinase -MB
- Myoglobin
- C-reactive protein
MI nursing intervention - Ans:✔✔-- ABCs
- Aspirin
- O2 if low
- monitor ECG
- repeat 12-lead ECG & blood work
- pain relief with nitrate first then opioid if needed
Page 4/61
